// App-Quantinova.ai

1144-187 : THREE-YEAR CLINICAL RESULTS OF PATIENTS RANDOMIZED TO 3 OR 12 MONTHS OF DUAL ANTIPLATELET AFTER ENDEAVOR ZOTAROLIMUS-ELUTING STENT IMPLANTATION IN OPTIMIZE

Researchers

Presenter

  • Fausto Feresa

Principal Investigators

  • Ricardo Costaa

  • Alexandre Abizaida

  • Jose Marin-Netoa

  • Roberto Botelhoa

  • Joao De Paulaa

  • Jose Mangionea

  • George Meirelesa

  • Helio Castelloa

  • Eduardo Nicolelaa

Medical Centers

  • Cardiovascular Research Center, Sao Paulo, Brazil

  • ICU, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stable coronary artery disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • ZoMaxx

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved